149 related articles for article (PubMed ID: 16447774)
1. [Pathogenesis and treatment of CIDP].
Sobue G
Rinsho Shinkeigaku; 2005 Nov; 45(11):963-5. PubMed ID: 16447774
[TBL] [Abstract][Full Text] [Related]
2. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
Hughes RA
Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
[TBL] [Abstract][Full Text] [Related]
5. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
Phillips LH
Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
[No Abstract] [Full Text] [Related]
6. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP.
Iijima M; Tomita M; Morozumi S; Kawagashira Y; Nakamura T; Koike H; Katsuno M; Hattori N; Tanaka F; Yamamoto M; Sobue G
Neurology; 2009 Oct; 73(17):1348-52. PubMed ID: 19776380
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.
Odaka M
Expert Rev Neurother; 2006 Mar; 6(3):365-79. PubMed ID: 16533141
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy.
Iijima M; Koike H; Katsuno M; Sobue G
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():52-5. PubMed ID: 21696500
[TBL] [Abstract][Full Text] [Related]
14. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kissel JT
Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
[TBL] [Abstract][Full Text] [Related]
15. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Lin CS; Krishnan AV; Park SB; Kiernan MC
Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
[TBL] [Abstract][Full Text] [Related]
17. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
Caro XJ; Winter EF; Dumas AJ
Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
[TBL] [Abstract][Full Text] [Related]
18. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
19. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
20. [Chronic inflammatory demyelinating polyradiculoneuropathy].
Franques J; Azulay JP; Pouget J; Attarian S
Rev Med Interne; 2010 Jun; 31(6):411-6. PubMed ID: 20395023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]